A Win For Cardlytics, Inc.
Mon 13 Jan 20 at 05:30 PM
Cardlytics, Inc. (CDLX:NASDAQ) shot up at $85.05, a gain of 24.7%. On Fri 10 Jan 20, CDLX:NASDAQ touched a New 2-Week Intraday High of $69.3. The stock got featured on our News Catalysts scanner on Mon 13 Jan 20 at 09:42 AM in the 'BIOTECH' category. From Thu 19 Dec 19, the stock recorded 71.43% Up Days and 73.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Cardlytics, Inc. (CDLX:NASDAQ)
Cardlytics Inc is an operator of purchase intelligence platform. It solution Cardlytics Direct enables marketers to deliver advertising content to FI customers in the form of an opportunity to earn rewards.
Top 10 Gainers:
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 200%
- Dare Bioscience, Inc. (DARE:NASDAQ), 97.6%
- NantKwest, Inc. (NK:NASDAQ), 91.01%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 50.4%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 46.15%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- iFresh Inc. (IFMK:NASDAQ), 29.67%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 28.77%
- Primo Water Corporation (PRMW:NASDAQ), 25.43%
- Cardlytics, Inc. (CDLX:NASDAQ), 24.65%